IndustryCompany release
Akebia secures up to $140M Symbiotic Capital term loan, repays $55M BlackRock facility
🇺🇸 Akebia Therapeutics, Inc. (AKBA) · Mon 16 Nov 2026
Akebia Therapeutics announced a senior secured term loan with Symbiotic Capital, closed November 12, 2026 and disclosed November 16, 2026. A $60 million initial tranche was funded and used to repay its $55 million BlackRock loan in full, and up to $80 million more may be provided at the lender's discretion. The loan matures in 60 months at a variable rate of at least 11.5%, and the company reaffirmed cash runway guidance of at least two years.
Company's press release (SEC filing): Akebia Therapeutics, Inc. ↗
Brief written by VigiEye from the company's press release filed with the SEC. Claims are the company's own. AI-assisted; check the source before acting.
More Industry
All →
Gedeon Richter to acquire Mayne Pharma in AUD 604 million cash deal
Gedeon Richter · Mon 16 Nov 2026
Metagenomi puts hemophilia A editing candidate MGX-001 first in November 2026 deck
🇺🇸 Metagenomi Therapeutics, Inc. (MGX) · Mon 16 Nov 2026
Lifeloc Q3 revenue rises 12% as SpinDetect drug analyzer launch slips to Q4 2027
🇺🇸 Lifeloc Technologies, Inc (LCTC) · Mon 16 Nov 2026
Aytu BioPharma to be acquired by Rosemont for about $56M as EXXUA sales grow
🇺🇸 Aytu Biopharma, Inc (AYTU) · Mon 16 Nov 2026
Merck KGaA to acquire Rapid Micro Biosystems in $0.75-per-share cash tender offer
🇺🇸 Rapid Micro Biosystems, Inc. (RPID) · Mon 16 Nov 2026
Glass House Brands more than doubles Q3 revenue to $56.8M as net loss narrows
Glass House Brands Inc. (GLAS) · Mon 16 Nov 2026